WebI primarily focused on heart failure with preserved ejection fraction (HFpEF), a disease affected by cardiac fibrosis with no current, effective, treatment options. I found that ECM … WebBackground: Heart failure with preserved ejection fraction (HFpEF) and HF with reduced ejection fraction (HFrEF) are associated with metabolic derangements, which may have …
Is RBM20 a Promising Target for HFpEF Therapy? - figshare.com
WebNearly half of all patients with heart failure have a normal ejection fraction (EF). The prevalence of this syndrome, termed heart failure with preserved ejection fraction (HFpEF), continues to increase in the developed world, likely because of the increasing prevalence of common risk factors, including older age, female sex, hypertension, metabolic syndrome, … WebPatients with severe HFPEF had significantly higher plasma Galectin-3 levels. Significant correlation between plasma Galectin-3 and E/Em in advanced HFPEF patients was noted. After 2 weeks of pressure overload in canine models, the protein expression of Galectin-3 from LV myocardial tissue was significantly increased (p < 0.01) compared with controls. poppy lee friar ackley bridge
Metabolomic Fingerprint of Heart Failure with Preserved Ejection …
WebApr 14, 2024 · image: The image shows human cells with a disease-causing RBM20 mutant: the cell nuclei are shown in light blue, the RBM20 protein in green and the MOV10 protein … WebRBM20 (RNA-binding motif protein 20) is a splicing factor targeting multiple cardiac genes, and its mutations cause cardiomyopathies. Originally, RBM20 mutations were discovered … WebHFpEF (n = 9), the same subjects several weeks later without symptoms (n = 7) and control subjects (n = 8). Mass spectrometry identified 6102 proteins with five scans with peptide … poppy legion shop